RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Paul Wang to Nanoparticles

This is a "connection" page, showing publications Paul Wang has written about Nanoparticles.
Connection Strength

0.877
  1. Zhang T, Guo W, Zhang C, Yu J, Xu J, Li S, Tian JH, Wang PC, Xing JF, Liang XJ. Transferrin-Dressed Virus-like Ternary Nanoparticles with Aggregation-Induced Emission for Targeted Delivery and Rapid Cytosolic Release of siRNA. ACS Appl Mater Interfaces. 2017 May 17; 9(19):16006-16014.
    View in: PubMed
    Score: 0.112
  2. Tuguntaev RG, Okeke CI, Xu J, Li C, Wang PC, Liang XJ. Nanoscale Polymersomes as Anti-Cancer Drug Carriers Applied for Pharmaceutical Delivery. Curr Pharm Des. 2016; 22(19):2857-65.
    View in: PubMed
    Score: 0.102
  3. Chen S, Yang K, Tuguntaev RG, Mozhi A, Zhang J, Wang PC, Liang XJ. Targeting tumor microenvironment with PEG-based amphiphilic nanoparticles to overcome chemoresistance. Nanomedicine. 2016 Feb; 12(2):269-86.
    View in: PubMed
    Score: 0.102
  4. Zhao Y, Chen F, Pan Y, Li Z, Xue X, Okeke CI, Wang Y, Li C, Peng L, Wang PC, Ma X, Liang XJ. Nanodrug Formed by Coassembly of Dual Anticancer Drugs to Inhibit Cancer Cell Drug Resistance. ACS Appl Mater Interfaces. 2015 Sep 02; 7(34):19295-305.
    View in: PubMed
    Score: 0.099
  5. Zhang J, Li S, An FF, Liu J, Jin S, Zhang JC, Wang PC, Zhang X, Lee CS, Liang XJ. Self-carried curcumin nanoparticles for in vitro and in vivo cancer therapy with real-time monitoring of drug release. Nanoscale. 2015 Aug 28; 7(32):13503-10.
    View in: PubMed
    Score: 0.099
  6. Xue X, Hall MD, Zhang Q, Wang PC, Gottesman MM, Liang XJ. Nanoscale drug delivery platforms overcome platinum-based resistance in cancer cells due to abnormal membrane protein trafficking. ACS Nano. 2013 Dec 23; 7(12):10452-64.
    View in: PubMed
    Score: 0.088
  7. Lin PC, Lin S, Wang PC, Sridhar R. Techniques for physicochemical characterization of nanomaterials. Biotechnol Adv. 2014 Jul-Aug; 32(4):711-26.
    View in: PubMed
    Score: 0.088
  8. Meng J, Wang DL, Wang PC, Jia L, Chen C, Liang XJ. Biomedical activities of endohedral metallofullerene optimized for nanopharmaceutics. J Nanosci Nanotechnol. 2010 Dec; 10(12):8610-6.
    View in: PubMed
    Score: 0.072
  9. Liang XJ, Chen C, Zhao Y, Wang PC. Circumventing tumor resistance to chemotherapy by nanotechnology. Methods Mol Biol. 2010; 596:467-88.
    View in: PubMed
    Score: 0.067
  10. Tan J, Li C, Wang Q, Li S, Chen S, Zhang J, Wang PC, Ren L, Liang XJ. A Carrier-Free Nanostructure Based on Platinum(IV) Prodrug Enhances Cellular Uptake and Cytotoxicity. Mol Pharm. 2018 04 02; 15(4):1724-1728.
    View in: PubMed
    Score: 0.030
  11. Guo S, Huang Y, Wei T, Zhang W, Wang W, Lin D, Zhang X, Kumar A, Du Q, Xing J, Deng L, Liang Z, Wang PC, Dong A, Liang XJ. Amphiphilic and biodegradable methoxy polyethylene glycol-block-(polycaprolactone-graft-poly(2-(dimethylamino)ethyl methacrylate)) as an effective gene carrier. Biomaterials. 2011 Jan; 32(3):879-89.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support